Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U54CA168512
National Institutes of Health
Grant: P30 CA016058
Cancer Prevention and Research Institute of Texas
Grant: CP130058
Desmoid Tumor Research Foundation
Iterion Therapeutics
MeSH Terms